Modifiers of γ-Globin Gene Expression and Treatment of β-Thalassemia

Beta thalassemia (β-thalassemia) is an autosomal recessive genetic disease with many genes involved. It is a heterogeneous disorder caused by variations in the inactivation mechanism of the Beta-globin (β-globin) genes. Despite seemingly similar genotypes, the patients with Beta-thalassemia have a remarkable variability in anaemia, growth development, and hepatospleenomegaly and transfusion requirements. The genetic factors may differ in each race or ethnic group for therapy and prevention. Despite re‐ markable successes in the treatment of Beta-thalassemia in the past decades, it is still the leading cause of death and premature disability in developed and developing countries. Possible factors that influence the severity of anaemia in thalassemia may be inherited or non-inherited. The inherited factors include the type of β-thalassemia, coinheritance of alpha thalassemia (α-thalassemia) and factors that stimulate fetal he‐ moglobin (HbF) production. In this chapter, respective contributions of known modi‐ fiers and also the pharmaceutical agents currently in use and under clinical trials for regulating the globin gene expression will be discussed.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-11-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.5772/61441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of BCL11A genetic variant (rs11886868) with severity in β-thalassaemia major & sickle cell anaemia

  2016influential reference
• Clinicoinvestigational and Demographic Profile of Children with Thalassemia Major

  2015cited by this paper
• Meta-analysis on effectiveness of hydroxyurea to treat transfusion-dependent beta-thalassemia

  2015cited by this paper
• Modulation of gamma globin genes expression by histone deacetylase inhibitors: an in vitro study

  2014cited by this paper
• [Beta-thalassemias: molecular, epidemiological, diagnostical and clinical aspects].

  2014cited by this paper
• A phase 2 study of HQK‐1001, an oral fetal haemoglobin inducer, in β‐thalassaemia intermedia

  2014cited by this paper
• Erasers of histone acetylation: the histone deacetylase enzymes.

  2014cited by this paper
• Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia—Current Status and Perspectives in Fetal Hemoglobin Reactivation

  2014cited by this paper
• Genetic variants at HbF‐modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania

  2014cited by this paper
• BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety

  2014cited by this paper
• Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells.

  2014cited by this paper
• Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells.

  2013cited by this paper
• Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia.

  2013cited by this paper
• Genetic association studies in β-hemoglobinopathies.

  2013cited by this paper
• Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia

  2013cited by this paper
• Primed for take-off

  2013cited by this paper
• Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction

  2013cited by this paper
• Expression of DNMTs and genomic DNA methylation in gastric signet ring cell carcinoma.

  2013cited by this paper
• β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life

  2012cited by this paper
• Hemoglobinopathies: Clinical Manifestations, Diagnosis, and Treatment

  2012cited by this paper
• Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).

  2012cited by this paper
• Pathophysiology and Clinical Manifestations of the β-Thalassemias.

  2012cited by this paper
• Thalidomide and its analogs for hemoglobinopathies: two birds with one stone?

  2012cited by this paper
• Induction of Human Fetal Hemoglobin Expression by Selective Inhibitors of Histone Deacetylase 1 and 2 (HDAC1/2)

  2012cited by this paper
• FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors

  2012cited by this paper
• The Ethanol Extract of Fructus trichosanthis Promotes Fetal Hemoglobin Production via p38 MAPK Activation and ERK Inactivation in K562 Cells

  2011cited by this paper
• Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice.

  2011cited by this paper
• Stroke with transfusions changing to hydroxyurea (SWiTCH): A phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload

  2011cited by this paper
• Hb E/beta-thalassaemia: a common & clinically diverse disorder

  2011cited by this paper
• Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

  2011cited by this paper
• Model-based gene set analysis for Bioconductor

  2011cited by this paper
• Recent advances in β-thalassemias

  2011cited by this paper
• Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease

  2010cited by this paper
• Fetal globin expression is regulated by Friend of Prmt1.

  2010influential reference
• The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

  2010cited by this paper
• Expression of zinc finger and homeobox 2 in erythroleukaemic cells and gamma-globin expression

  2010cited by this paper
• Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

  2010cited by this paper
• Comprehensive Spectrum of the β-Thalassemia Mutations in Khuzestan, Southwest Iran

  2010cited by this paper
• Histone Deacetylase 9 Activates γ-Globin Gene Expression in Primary Erythroid Cells*

  2010cited by this paper
• Organization of transcription.

  2010cited by this paper
• Beta-thalassemia

  2010cited by this paper
• Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6.

  2010cited by this paper
• Haploinsufficiency for the erythroid transcription factor KLF1 causes Hereditary Persistence of Fetal Hemoglobin

  2010cited by this paper
• Expression of New Red Cell–Related Genes in Erythroid Differentiation

  2010cited by this paper
• Bergamot (Citrus bergamia Risso) fruit extracts as γ-globin gene expression inducers: phytochemical and functional perspectives.

  2009cited by this paper
• Discovering the genetics underlying foetal haemoglobin production in adults

  2009cited by this paper
• Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease.

  2009cited by this paper
• A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia

  2009cited by this paper
• Opening act in a hematopoietic program.

  2009cited by this paper
• The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells.

  2009cited by this paper
• Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea

  2008cited by this paper
• Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential.

  2008cited by this paper
• A T-to-G Transversion at Nucleotide −567 Upstream of HBG2 in a GATA-1 Binding Motif Is Associated with Elevated Hemoglobin F

  2008cited by this paper
• Silencing of Aγ-Globin Gene Expression during Adult Definitive Erythropoiesis Mediated by GATA-1-FOG-1-Mi2 Complex Binding at the −566 GATA Site

  2008cited by this paper
• DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease

  2008cited by this paper
• A shifting paradigm: histone deacetylases and transcriptional activation

  2008cited by this paper
• Characterization of a novel deletion causing (deltabeta)0-thalassemia in a Thai family.

  2007cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobin.

  2007cited by this paper
• Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults

  2007cited by this paper
• Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia.

  2007cited by this paper
• Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin

  2007cited by this paper
• A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15

  2007cited by this paper
• Histone Deacetylase Inhibitors: Overview and Perspectives

  2007cited by this paper
• Role of S-adenosylhomocysteine hydrolase in adenosine-induced apoptosis in HepG2 cells.

  2007cited by this paper
• HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention

  2007cited by this paper
• Embryonic and fetal β‐globin gene repression by the orphan nuclear receptors, TR2 and TR4

  2007cited by this paper
• Oral decitabine reactivates expression of the methylated gamma-globin gene in Papio anubis.

  2007cited by this paper
• Identification of novel candidate genes for globin regulation in erythroid cells containing large deletions of the human beta-globin gene cluster.

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Induction of fetal hemoglobin in the treatment of sickle cell disease.

  2006cited by this paper
• American Ginseng Stimulates Insulin Production and Prevents Apoptosis through Regulation of Uncoupling Protein-2 in Cultured β Cells

  2006cited by this paper
• Short-chain fatty acids induce gamma-globin gene expression by displacement of a HDAC3-NCoR repressor complex.

  2006cited by this paper
• Evaluation of Cytotoxic Effects of Dichloromethane Extract of Guduchi (Tinospora cordifolia Miers ex Hook F & THOMS) on Cultured HeLa Cells

  2006cited by this paper
• Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11AXL protein are frequent in primary mediastinal B-cell lymphoma

  2006cited by this paper
• Methyl binding domain protein 2 mediates gamma-globin gene silencing in adult human betaYAC transgenic mice.

  2006cited by this paper
• Transcriptional control in the mammalian liver: liver development, perinatal repression, and zonal gene regulation

  2006cited by this paper
• Hospitalization rates and costs of care of patients with sickle‐cell anemia in the state of Maryland in the era of hydroxyurea

  2006cited by this paper
• cMYB is involved in the regulation of fetal hemoglobin production in adults.

  2006cited by this paper
• DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.

  2006cited by this paper
• Methylation of Histone H3 Mediates the Association of the NuA3 Histone Acetyltransferase with Chromatin

  2006cited by this paper
• Enhancement of growth and survival and alterations in Bcl-family proteins in beta-thalassemic erythroid progenitors by novel short-chain fatty acid derivatives.

  2005cited by this paper
• Induction of Fetal Globin in β‐Thalassemia: Cellular Obstacles and Molecular Progress

  2005cited by this paper
• Adult stage gamma-globin silencing is mediated by a promoter direct repeat element.

  2005cited by this paper
• Hemoglobin E-beta-thalassemia: Progress report from the International Study Group.

  2005cited by this paper
• Acetylation and deacetylation of non-histone proteins.

  2005cited by this paper
• Histone deacetylation in epigenetics: An attractive target for anticancer therapy

  2005cited by this paper
• Hereditary persistence of alpha-fetoprotein and H19 expression in liver of BALB/cJ mice is due to a retrovirus insertion in the Zhx2 gene.

  2005cited by this paper
• GATA Transcription Factors Inhibit Cytokine-dependent Growth and Survival of a Hematopoietic Cell Line through the Inhibition of STAT3 Activity*

  2005cited by this paper
• Fetal globin induction--can it cure beta thalassemia?

  2005cited by this paper
• Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study.

  2005cited by this paper
• Tradition and Perspectives of Arab Herbal Medicine: A Review

  2005cited by this paper
• Sox6 Directly Silences Epsilon Globin Expression in Definitive Erythropoiesis

  2005cited by this paper
• Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid.

  2005cited by this paper
• Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites.

  2005cited by this paper
• Pathophysiology of beta thalassemia--a guide to molecular therapies.

  2005cited by this paper
• Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.

  2004cited by this paper
• Pharmacological Induction of Fetal Hemoglobin Synthesis using Histone Deacetylase Inhibitors

  2004cited by this paper
• Effects of extracts from Bangladeshi medicinal plants on in vitro proliferation of human breast cancer cell lines and expression of estrogen receptor alpha gene.

  2004cited by this paper
• Clinical studies with fetal hemoglobin-enhancing agents in sickle cell disease.

  2004cited by this paper

• The Genetic Aspect of Thalassemia: From Diagnosis to Treatment

  2018cites this paper
• Homozygous Mutation on the β-Globin Polyadenylation Signal in a Tunisian Patient with β-Thalassemia Intermedia and Coinheritance of Gilbert’s Syndrome

  2017cites this paper